EPIRUS Biopharmaceuticals, Inc. Retained Earnings
EPIRUS Biopharmaceuticals, Inc. had Retained Earnings of -$155.03 million as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2016-05-10
- 2016-03-31: Retained Earnings (Accumulated Deficit) -$155.03M.
- 2015-12-31: Retained Earnings (Accumulated Deficit) -$138.76M.
- 2015-09-30: Retained Earnings (Accumulated Deficit) -$123.36M.
- 2015-06-30: Retained Earnings (Accumulated Deficit) -$109.38M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2016-03-31 | -$155.03M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$138.76M 10-Q · filed 2016-05-10 | |
| 2015-09-30 | -$123.36M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$109.38M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | -$94.09M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | -$86.57M 10-K · filed 2016-03-29 | |
| 2014-09-30 | -$76.17M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$380.09M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$383.43M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -$44.73M 10-K · filed 2015-03-31 | -$379.64M 10-K · filed 2014-03-14 |
| 2013-09-30 | -$370.16M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | -$359.63M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | -$349.07M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | -$341.02M 10-K · filed 2014-03-14 | |
| 2012-09-30 | -$332.74M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$320.56M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | -$310.24M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | -$296.70M 10-K · filed 2013-03-07 | |
| 2011-09-30 | -$285.93M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | -$276.68M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | -$254.65M 10-K · filed 2012-03-09 |